1. Home
  2. TIRX vs LYRA Comparison

TIRX vs LYRA Comparison

Compare TIRX & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIRX
  • LYRA
  • Stock Information
  • Founded
  • TIRX 2010
  • LYRA 2005
  • Country
  • TIRX China
  • LYRA United States
  • Employees
  • TIRX N/A
  • LYRA 30
  • Industry
  • TIRX Specialty Insurers
  • LYRA Medical/Dental Instruments
  • Sector
  • TIRX Finance
  • LYRA Health Care
  • Exchange
  • TIRX Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • TIRX 14.0M
  • LYRA 15.0M
  • IPO Year
  • TIRX 2021
  • LYRA 2020
  • Fundamental
  • Price
  • TIRX $1.26
  • LYRA $10.65
  • Analyst Decision
  • TIRX
  • LYRA Buy
  • Analyst Count
  • TIRX 0
  • LYRA 2
  • Target Price
  • TIRX N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • TIRX 1.2M
  • LYRA 1.9M
  • Earning Date
  • TIRX 08-15-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • TIRX N/A
  • LYRA N/A
  • EPS Growth
  • TIRX N/A
  • LYRA N/A
  • EPS
  • TIRX N/A
  • LYRA N/A
  • Revenue
  • TIRX $3,219,336.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • TIRX N/A
  • LYRA N/A
  • Revenue Next Year
  • TIRX N/A
  • LYRA $1,286.17
  • P/E Ratio
  • TIRX N/A
  • LYRA N/A
  • Revenue Growth
  • TIRX 158.74
  • LYRA N/A
  • 52 Week Low
  • TIRX $1.07
  • LYRA $3.81
  • 52 Week High
  • TIRX $4.15
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • TIRX 42.23
  • LYRA 48.18
  • Support Level
  • TIRX $1.25
  • LYRA $9.81
  • Resistance Level
  • TIRX $1.45
  • LYRA $27.42
  • Average True Range (ATR)
  • TIRX 0.12
  • LYRA 5.15
  • MACD
  • TIRX -0.02
  • LYRA -1.04
  • Stochastic Oscillator
  • TIRX 2.22
  • LYRA 7.52

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: